Sensei Biotherapeutics Inc Share Price

NASDAQ: SNSE

Small Cap

$9.02

+0.04

(+0.47%)

as on September 16, 2025 at 1:26 am IST

$₹

Sensei Biotherapeutics Inc Stock Performance

as on September 16, 2025 at 1:26 am IST

Day's High
$9.02
Day's Price Range
$9.49
$9.02
5.21%
Upside
52 Week's Low
52 Week's High
$5
52-Week Price Range
$17.4
$9.02
44.57%
Downside
92.90%
Upside

Sensei Biotherapeutics Inc share price movements today

Previous Close: $8.98
Open: $9.49
Volume: 8.3K
Day's Low - High: $9.02 - $9.49
52 Week Low - High: $5 - $17.4

Sensei Biotherapeutics Inc Historical Returns

1 Month Return: + 3.46 %
3 Month Return: + 49.67 %
1 Year Return: -16.85 %
3 Year Return: -77.66 %
5 Year Return: 0 %

Sensei Biotherapeutics Inc Stock Fundamentals & Key Indicators

Check Sensei Biotherapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$11.3M

EPS (TTM)

-15.71

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

EBITDA

-26.2M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

5314200.00%

Sensei Biotherapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Sensei Biotherapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Sensei Biotherapeutics Inc	BUY	$11.3M	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$61.1B	256.98%	-505.15	-12.96%
Beone Medicines Ltd	NA	$38.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$101.1B	47.85%	28.07	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.4B	-3.43%	14.11	31.37%

Stock Returns calculator for Sensei Biotherapeutics Inc Stock including INR - Dollar returns

The Sensei Biotherapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Sensei Biotherapeutics Inc investment value today

Current value as on today

₹88,504

Returns

₹11,496

(-11.5%)

Returns from Sensei Biotherapeutics Inc Stock

₹16,481 (-16.48%)

Dollar Returns*

₹4,985 (+4.99%)

Analyst Recommendation on Sensei Biotherapeutics Inc Stock

Based on 10 analysts

BUY

90.00%

Buy

10.00%

Hold

0.00%

Sell

Based on 10 analysts, 90% of analysts recommend a 'BUY' rating for Sensei Biotherapeutics Inc. Average target price of $32.5

Sensei Biotherapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Sensei Biotherapeutics Inc.

What analysts predicted

72.25%UPSIDE

Target Price

$32.5

Current Price

$9.02

Analyzed by

10 Analysts

Target

$32.50

Sensei Biotherapeutics Inc target price $32.5, a slight upside of 72.25% compared to current price of $9.02. According to 10 analysts rating.

Sensei Biotherapeutics Inc Stock's Interest Amongst Investors

Search interest for Sensei Biotherapeutics Inc Stock has decreased by -65% in the last 30 days, reflecting a downward trend in search activity.

Time period: August 17, 2025 to September 16, 2025

Change:-65% versus previous 30 day period

Sensei Biotherapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	2	-	-	-	0	-	-
Gross Profit	0	0	0	2	0	0	0	0	0	-
Operating Income	-11	-10	-7	-8	-8	-7	-7	-8	-7	-5
EBITDA	-9	-8	-6	-7	-7	-6	-6	-7	-6	-5
Interest Expense	0	0	0	0	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-10	-9	-7	-7	-7	-7	-7	-7	-6	-4
Income Tax Expense	0	0	0	1	0	-	-	-	-	-
Net Income	-10	-9	-7	-7	-7	-7	-7	-7	-6	-4
Net Profit Margin	0.00%	0.00%	0.00%	-260.51%	0.00%	0.00%	0.00%	-1428.31%	0.00%	0.00%

Sensei Biotherapeutics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-	-	-	-	-
Gross Profit	0	0	0	0	-1	0	0
Operating Income	-12	-12	-19	-37	-50	-37	-32
EBITDA	-12	-12	-18	-35	-48	-33	-29
Interest Expense	0	2	1	0	0	0	0
Depreciation	0	0	0	0	1	1	1
Income Before Tax	-13	-16	-20	-36	-48	-34	-30
Income Tax Expense	0	2	0	0	0	0	-
Net Income	-13	-16	-20	-36	-48	-34	-30
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Sensei Biotherapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-9	-7	-7	-7	-7	-7	-7	-6	-4
Operating Cash Flow	-9	-4	-6	-7	-5	-5	-5	-7	-5
Investing Cash Flow	19	8	8	5	6	12	-3	7	8
Financing Cash Flow	-7	-2	0	0	0	0	0	0	0
Change in Cash	2	1	1	-2	0	7	-9	0	2

Sensei Biotherapeutics Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-16	-20	-36	-48	-34	-30
Operating Cash Flow	-8	-17	-30	-39	-32	-24
Investing Cash Flow	0	-1	-143	49	38	22
Financing Cash Flow	8	35	163	0	-11	0
Change in Cash	0	16	-9	10	-4	-3

Global Institutional Holdings in Sensei Biotherapeutics Inc

Funds	Holdings
Vanguard Group Inc	2.32%
Ikarian Capital, LLC	1.78%
Catalio Capital Management, LP	1.17%
Renaissance Technologies Corp	0.7%
Geode Capital Management, LLC	0.6%

See all

Insights on Sensei Biotherapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 7 days, SNSE stock has moved up by 13.2%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 123.5% return, outperforming this stock by 201.2%
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.6% return, outperforming this stock by 92.5%

About Sensei Biotherapeutics Inc

sensei biotherapeutics is an innovator in the field of next-generation cancer immunotherapies. sensei has pioneered a proprietary immuno-oncology technology platform, called spirit, to aid the immune system in the detection and elimination of cancer. the presence of subtle differences in antigen expression between cancer and normal is key to this process the spirit platform overcomes disabled immune recognition caused by cancer. the immune system has evolved to protect its host from foreign pathogens, effectively distinguishing healthy ‘self’ tissues from ‘non-self’. cancer is a unique challenge to the immune system. it arises from ‘self’ making immune recognition challenging, yet it is known to be altered. immune recognition of the subtle differences between ‘self’ and ‘non-self’ is key to effective cancer immunotherapy. headquartered in gaithersburg, md, sensei has built a unique and proprietary approach in-house and in collaboration with key academic collaborators at brown universit

Organisation	Sensei Biotherapeutics Inc
Headquarters	1405 Research Boulevard, Rockville, MD, United States, 20850
Industry	Services
CEO	Mr. John K. Celebi M.B.A.
E-voting on shares	Click here to vote

Key Management of Sensei Biotherapeutics Inc

Name	Title
Mr. Christopher W. Gerry J.D.	Senior VP, General Counsel & Secretary
Dr. Aaron Weitzman FACP, M.D., Ph.D.	Chief Medical Officer
Mr. John K. Celebi M.B.A.	President, CEO & Director
Dr. Edward Van der Horst Ph.D.	Chief Scientific Officer
Ms. Stephanie Krebs M.B.A., M.S.	Chief Business Officer
Mr. Josiah Craver	Senior VP of Finance, Principal Financial Officer & Principal Accounting Officer
Ms. Lora Pike	Vice President of Investor Relations & Communications

FAQs

What is Sensei Biotherapeutics Inc share price today?

Sensei Biotherapeutics Inc share price today is $9.02 as on September 16, 2025 at 1:26 am IST at the close of the market. Sensei Biotherapeutics Inc share today touched a day high of $9.49 and a low of $9.02.

What is the 52 week high and 52 week low for Sensei Biotherapeutics Inc share?

Sensei Biotherapeutics Inc share touched a 52 week high of $17.4 on October 21, 2024 and a 52 week low of $5 on March 31, 2025. Sensei Biotherapeutics Inc stock price today i.e. September 16, 2025 at 1:26 am IST is closed at $9.02,which is 48.16% down from its 52 week high and 80.40% up from its 52 week low.

What is Sensei Biotherapeutics Inc's market capitalisation today?

Sensei Biotherapeutics Inc market capitalisation is $0.00T as on September 16, 2025 at 1:26 am IST.

How to invest in Sensei Biotherapeutics Inc Stock (SNSE) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Sensei Biotherapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Sensei Biotherapeutics Inc Shares that will get you 0.1663 shares as per Sensei Biotherapeutics Inc share price of $9.02 per share as on September 16, 2025 at 1:26 am IST.

What is the minimum amount required to buy Sensei Biotherapeutics Inc Stock (SNSE) from India?

Indian investors can start investing in Sensei Biotherapeutics Inc (SNSE) shares with as little as ₹88.141 or $1 (as of September 16, 2025 at 1:41 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹881.41 in Sensei Biotherapeutics Inc stock (as per the Rupee-Dollar exchange rate as on September 16, 2025 at 1:41 am IST). Based on Sensei Biotherapeutics Inc share’s latest price of $9.02 as on September 16, 2025 at 1:26 am IST, you will get 1.1086 shares of Sensei Biotherapeutics Inc. Learn more about fractional shares .